与易布鲁替尼使用相关的双边非瘤前水道炎与斑点:一个病例报告
Jairo Alonso Gómez Mejía1,2, Claudia Duran1,3, Martha Luz Zuluaga4,5
1Ophthalmology Clinic, San Diego Clinic, Medellín, Colombia.
Ocular immunology and inflammation
|December 23, 2025
概括
易布鲁替尼是慢性淋巴细胞白血病 (CLL) 的治疗药物,可引起眼部的副作用,如脑膜炎和黄斑. 早期诊断和眼科评估对于在ibrutinib治疗期间出现视觉症状的患者至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种常见的血液性恶性瘤.
- 易布鲁替尼是用于治疗CLL的向疗法.
- 眼部不良事件是全身疗法的潜在并发症.
研究的目的:
- 在接受ibrutinib治疗的CLL患者中报告双边前性脑膜炎和囊性黄斑胀病例.
- 为了将这种情况与以前记录的与易布鲁替尼相关的眼部副作用进行比较.
主要方法:
- 一个60岁的男性患有CLL在ibrutinib治疗中的病例报告.
- 眼科检查包括视力敏,裂纹灯生物显微镜和光学连贯性断层扫描 (OCT).
- 治疗涉及局部皮质类固醇,NSAIDs和mydriatics,并继续治疗易布鲁替尼.
主要成果:
- 患者出现视力敏度下降,前腔炎症和囊性黄斑 (视网膜中心厚度为528μm).
- 眼部炎症通过局部治疗和持续治疗ibrutinib而消失.
- 干预后视力敏度有所改善.
结论:
- 易布鲁替尼治疗可能与显著的眼部不良反应有关,包括眼膜炎和黄斑.
- 早期识别和眼科咨询对于管理这些副作用至关重要.
- 及时干预可以导致接受ibrutinib的患者获得有利的视觉结果.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179
Open Angle Glaucoma: Treatment
920
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
920
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Nephrotic Syndrome I : Introduction
460
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
460
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405


